SEC 13F Intelligence

Managers / Q3 2022 · view latest →

BRIDGER MANAGEMENT, LLC

CIK 0001166309 · 90 PARK AVENUE, 40TH FLOOR, NEW YORK, NY, 10016 · 212-918-0820

Reported Value
$330M
Q3 2022
Positions
44
Filings on Record
37
2019–present window
Filed
Nov 14, 2022
original filing

Summary

Bridger Management, LLC reported $330M in U.S.-listed holdings across 44 positions for Q3 2022.

Its largest position, UBER, represents 10.0% of the portfolio.

Compared with Q2 2022, the fund opened 5 new positions and exited 5.

Portfolio Metrics

Turnover
+10.3%
vs prior filed quarter
Top-10 Concentration
+56.5%
share of reported value
Largest Position
+10.0%
Uber Technologies
New / Exited
5 / 5
positions this quarter

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q4 ’18: $1.2BQ4 ’18Q1 ’19: $1.3BQ2 ’19: $1.3BQ3 ’19: $1.2BQ4 ’19: $1.4BQ4 ’19Q1 ’20: $864MQ2 ’20: $1.1BQ3 ’20: $1.3BQ4 ’20: $1.3BQ4 ’20Q1 ’21: $1.1BQ2 ’21: $1.1BQ3 ’21: $855MQ4 ’21: $773MQ4 ’21Q1 ’22: $610MQ2 ’22: $444MQ3 ’22: $330MQ4 ’22: $247MQ4 ’22Q1 ’23: $268MQ2 ’23: $300MQ3 ’23: $272MQ4 ’23: $260MQ4 ’23Q1 ’24: $222MQ2 ’24: $194MQ3 ’24: $200MQ4 ’24: $186MQ4 ’24Q1 ’25: $201MQ2 ’25: $170MQ3 ’25: $186MQ4 ’25: $156MQ4 ’25Q1 ’26: $128Mfilingsflow.com

Portfolio Composition

By security type
Common Stock: 73.8%Other: 19.3%ADR: 6.7%ETP: 0.2%Equity WRT: 0.0%
  • Common Stock · 73.8% · $243M
  • Other · 19.3% · $64M
  • ADR · 6.7% · $22M
  • ETP · 0.2% · $499,000
  • Equity WRT · 0.0% · $129,000

Quarter-over-Quarter Changes full breakdown →

vs Q2 2022 (amended baseline)

IssuerMoveShare ΔShares nowValue ΔValue now
KARUNA THERAPEUTICS INCNEW+28.6K28.6K+$6M$6M
MDUMDU RES GROUP INCNEW+175.5K175.5K+$5M$5M
2655787DBLUEPRINT MEDICINES CORPNEW+53.3K53.3K+$4M$4M
STAASTAAR SURGICAL CONEW+46.5K46.5K+$3M$3M
MELCO RESORTS AND ENTMNT LTDNEW+200.0K200.0K+$1M$1M
R1 RCM INCADDED+188.8K374.8K+$3M$7M
CLARIVATE PLCSOLD OUT−1.64M0−$23M$0
PODDINSULET CORPSOLD OUT−41.0K0−$9M$0

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q3 2022

41 positions
Export to Excel
#IssuerClass% PortfolioValue ↓Shares
1UBERUBER TECHNOLOGIES INChistory →COM10.02%$33M1.25M
2DWDMORGAN STANLEYhistory →COM NEW8.20%$27M342.2K
3GDDYGODADDY INChistory →CL A7.83%$26M364.4K
4CHTRCHARTER COMMUNICATIONS INC Nhistory →CL A6.27%$21M68.2K
5ALCON AGORD SHS4.76%$16M269.9K
6IRTCIRHYTHM TECHNOLOGIES INChistory →COM4.59%$15M120.9K
7CZRCAESARS ENTERTAINMENT INC NEhistory →COM4.03%$13M411.8K
8TEVATEVA PHARMACEUTICAL INDS LTDhistory →SPONSORED ADS3.67%$12M1.50M
9POST HOLDINGS PARTNERING CORUNIT 99/99/99993.66%$12M1.25M
10VRTXVERTEX PHARMACEUTICALS INChistory →COM3.49%$12M39.8K
11HUMHUMANA INChistory →COM3.09%$10M21.0K
12AVANTI ACQUISITION CORPUNIT 99/99/99993.03%$10M1.00M
13WILLIAMS ROWLAND ACQUISITIONCOM · *W EXP 12/11/2022.91%$10M1.43M
14IRWDIRONWOOD PHARMACEUTICALS INChistory →COM CL A2.88%$9M916.3K
15AZNNASTRAZENECA PLChistory →SPONSORED ADR2.60%$9M156.4K
16BMRNBIOMARIN PHARMACEUTICAL INChistory →COM2.58%$9M100.4K
17AIRSAIRSCULPT TECHNOLOGIES INChistory →COM2.53%$8M1.30M
18POSTPOST HLDGS INChistory →COM2.49%$8M100.3K
19VRSNVERISIGN INChistory →COM2.47%$8M47.0K
20R1 RCM INCCOM2.11%$7M374.8K
21KARUNA THERAPEUTICS INCCOM1.95%$6M28.6K
22SKIN2EURTHE BEAUTY HEALTH COMPANYhistory →COM CL A1.60%$5M446.6K
23FLAME ACQUISITION CORPCOM CL A1.49%$5M500.0K
24MDUMDU RES GROUP INChistory →COM1.46%$5M175.5K
25DCBODOCEBO INChistory →COM1.24%$4M150.3K
26BRBRBELLRING BRANDS INChistory →COMMON STOCK1.17%$4M187.1K
272655787DBLUEPRINT MEDICINES CORPhistory →COM1.07%$4M53.3K
28STAASTAAR SURGICAL COCOM PAR $0.011.00%$3M46.5K
29RXSTRXSIGHT INCCOM0.81%$3M221.7K
30CNCCENTENE CORP DELCOM0.67%$2M28.3K
31QTRXQUANTERIX CORPCOM0.66%$2M198.6K
32ABCAM PLCADS0.65%$2M142.3K
33XENEXENON PHARMACEUTICALS INCCOM0.50%$2M45.2K
34PRVAPRIVIA HEALTH GROUP INCCOM0.49%$2M47.7K
35SRZNWSURROZEN INCCOM · *W EXP 08/01/2030.47%$2M1.40M
36LIVANOVA PLCSHS0.41%$1M26.8K
37MELCO RESORTS AND ENTMNT LTDADR0.40%$1M200.0K
38NAUTNAUTILUS BIOTECHNOLOGY INCCOM0.27%$877,000413.7K
39DMTKQDERMTECH INCCOM0.25%$826,000208.6K
40MSOSADVISORSHARES TRPURE US CANNABIS0.15%$499,00056.0K
41NEXI1EURNEXIMMUNE INCCOM0.07%$222,000400.0K

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q1 2026$128M24May 15, 202613F-HRchanges · EDGAR ↗
Q4 2025$156M24Feb 17, 202613F-HRchanges · EDGAR ↗
Q3 2025$186M28Nov 14, 202513F-HRchanges · EDGAR ↗
Q2 2025$170M25Aug 11, 202513F-HRchanges · EDGAR ↗
Q1 2025$201M29May 15, 202513F-HRchanges · EDGAR ↗
Q4 2024$186M28Feb 14, 202513F-HRchanges · EDGAR ↗
Q3 2024$200M29Nov 14, 202413F-HRchanges · EDGAR ↗
Q2 2024$194M28Aug 14, 202413F-HRchanges · EDGAR ↗
Q1 2024$222M31May 15, 202413F-HRchanges · EDGAR ↗
Q4 2023$260M28Feb 14, 202413F-HRchanges · EDGAR ↗
Q3 2023$272M31Nov 14, 202313F-HRchanges · EDGAR ↗
Q2 2023$300M29Aug 14, 202313F-HRchanges · EDGAR ↗
Q1 2023$268M28May 15, 202313F-HRchanges · EDGAR ↗
Q4 2022$247M23Feb 15, 202313F-HRchanges · EDGAR ↗
Q3 2022$330M44Nov 14, 202213F-HRchanges · EDGAR ↗
Q2 2022$444M43Aug 15, 202213F-HRchanges · EDGAR ↗
Q1 2022$610M52May 13, 202213F-HRchanges · EDGAR ↗
Q4 2021$773M44Feb 14, 202213F-HRchanges · EDGAR ↗
Q3 2021$855M46Nov 15, 202113F-HRchanges · EDGAR ↗
Q2 2021$1.1B44Aug 16, 202113F-HRchanges · EDGAR ↗
Q1 2021$1.1B42May 14, 202113F-HRchanges · EDGAR ↗
Q4 2020$1.3B39Feb 16, 202113F-HRchanges · EDGAR ↗
Q3 2020$1.3B36Nov 16, 202013F-HRchanges · EDGAR ↗
Q2 2020$1.1B35Aug 14, 202013F-HRchanges · EDGAR ↗
Q1 2020$864M36May 15, 202013F-HRchanges · EDGAR ↗
Q4 2019$1.4B35Feb 14, 202013F-HRchanges · EDGAR ↗
Q3 2019$1.2B30Nov 14, 201913F-HRchanges · EDGAR ↗
Q2 2019$1.3B31Aug 14, 201913F-HRchanges · EDGAR ↗
Q1 2019$1.3B33May 15, 201913F-HRchanges · EDGAR ↗
Q4 2018$1.2B34Feb 14, 201913F-HRchanges · EDGAR ↗

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.